This phenomenon was consistent with the half-life of prothrombin (clotting factor II) and its major effect in the coagulation cascade.[17,18] The risk of hemorrhagic events was statistically significantly increased in patients who used anticoagulants as well as in patients with liver failure, poor nutritional status, and history of hemorrhagic events. Here, F2 is linked to liver failure.